期刊
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
卷 29, 期 3, 页码 390-396出版社
AMER THORACIC SOC
DOI: 10.1165/rcmb.2002-0271OC
关键词
-
Cystic fibrosis (CF) transmembrane conductance regulator (CFTR) genotype does not explain the heterogeneity observed in CF pulmonary disease severity. Modifier genes are implicated for this heterogeneity. alpha(1)-antitrypsin (alpha(1)-AT) is one of the few antiproteases capable of inactivating neutrophil elastase. We investigated whether alpha(1)-AT alleles (Z, S deficiency alleles and the 3 'G(1237)-->A mutation) were associated with increased disease severity and the alpha(1)-AT acute phase response during pulmonary exacerbations. This was a multicenter Canadian study. Seven hundred sixteen patients with CF (age range, 5.0-63.6 yr) were genotyped for the Z, S, and G(1237)-->A polymorphisms of the alpha(1)-AT gene. Stable and acute levels of alpha(1)-AT were ' measured on 31 adult patients with CF and were correlated,to clinical parameters. There were 69, 13, and 18 patients with CF who were MS, SS, and MZ, respectively. There were 95 and 7 patients with CF heterozygous or homozygous for the A(1237) allele, respectively. alpha(1)-AT genotype did not predict pulmonary disease severity, and was not associated with more severe clinical outcome (death or lung transplantation) or age of onset of Pseudomonas aeruginosa infection. Body mass index was a significant predictor lof alpha(1)-AT levels during exacerbations. alpha(1)-AT genotype is not a major contributor to the variability of pulmonary disease severity in CF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据